Immune infiltrates in breast cancer: recent updates and clinical implications
MV Dieci, F Miglietta, V Guarneri - Cells, 2021 - mdpi.com
In recent decades, the increasing interest in the field of immunotherapy has fostered an
intense investigation of the breast cancer (BC) immune microenvironment. In this context …
intense investigation of the breast cancer (BC) immune microenvironment. In this context …
Clinical implications of the intrinsic molecular subtypes of breast cancer
Gene-expression profiling has had a considerable impact on our understanding of breast
cancer biology. During the last 15 years, 5 intrinsic molecular subtypes of breast cancer …
cancer biology. During the last 15 years, 5 intrinsic molecular subtypes of breast cancer …
[HTML][HTML] Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast …
ABSTRACT The 14th St Gallen International Breast Cancer Conference (2015) reviewed
substantial new evidence on locoregional and systemic therapies for early breast cancer …
substantial new evidence on locoregional and systemic therapies for early breast cancer …
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
B Wallden, J Storhoff, T Nielsen, N Dowidar… - BMC medical …, 2015 - Springer
Background The four intrinsic subtypes of breast cancer, defined by differential expression of
50 genes (PAM50), have been shown to be predictive of risk of recurrence and benefit of …
50 genes (PAM50), have been shown to be predictive of risk of recurrence and benefit of …
Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
Epithelial‐mesenchymal transition (EMT) is a reversible and dynamic process hypothesized
to be co‐opted by carcinoma during invasion and metastasis. Yet, there is still no …
to be co‐opted by carcinoma during invasion and metastasis. Yet, there is still no …
Association of peritumoral radiomics with tumor biology and pathologic response to preoperative targeted therapy for HER2 (ERBB2)–positive breast cancer
Importance There has been significant recent interest in understanding the utility of
quantitative imaging to delineate breast cancer intrinsic biological factors and therapeutic …
quantitative imaging to delineate breast cancer intrinsic biological factors and therapeutic …
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive …
A Llombart-Cussac, J Cortés, L Paré, P Galván… - The lancet …, 2017 - thelancet.com
Background HER2-positive breast cancer consists of four intrinsic molecular subtypes—
luminal A, luminal B, HER2-enriched, and basal-like—and a normal-like subtype, with the …
luminal A, luminal B, HER2-enriched, and basal-like—and a normal-like subtype, with the …
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial …
L Gianni, W Eiermann, V Semiglazov, A Lluch… - The Lancet …, 2014 - thelancet.com
Background In our randomised, controlled, phase 3 trial NeOAdjuvant Herceptin (NOAH)
trial in women with HER2-positive locally advanced or inflammatory breast cancer …
trial in women with HER2-positive locally advanced or inflammatory breast cancer …
Tumor-derived cell lines as molecular models of cancer pharmacogenomics
Compared with normal cells, tumor cells have undergone an array of genetic and epigenetic
alterations. Often, these changes underlie cancer development, progression, and drug …
alterations. Often, these changes underlie cancer development, progression, and drug …
Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer
JM Cejalvo, E Martínez de Dueñas, P Galván… - Cancer research, 2017 - AACR
Biological changes that occur during metastatic progression of breast cancer are still
incompletely characterized. In this study, we compared intrinsic molecular subtypes and …
incompletely characterized. In this study, we compared intrinsic molecular subtypes and …